Our potential impact is beyond measure
We are committed to the discovery and development of a transformational generation of targeted therapies for women’s cancers. Led by a team of professionals with a deep understanding of endocrine-driven cancers and extensive development expertise, we are persistent in our pursuit of advancing the standard of care for women living with cancer.
Our Team
leadership
board of directors
leadership
board of directors
leadership
Sean P. Bohen, M.D., Ph.D.
Shane Kovacs
Naseem Zojwalla, M.D.
David C. Myles, Ph.D.
Julie Dexter
Sasha Austin, CPA
Demiana Faltaos, PharmD, Ph.D.
Richard Hernandez
Kamesh Kuchimanchi, Ph.D.
Kristin Lanzi
Geoffrey Mogilner
Gopinath Palanisamy, DVM, Ph.D., DACVP
Mark Shilkrut, M.D., Ph.D.
Rachel Wei, Ph.D.
Jim Zhang, Ph.D.
Sean P. Bohen, M.D., Ph.D.
Ian Clark
Cindy Butitta
Scott Garland
Cyrus Harmon, Ph.D.
Sandra J. Horning, M.D., FACP, FASCO
Gorjan Hrustanovic, Ph.D.
Yi Larson, MBA
Andy Rappaport
Graham Walmsley, M.D., Ph.D.